Gernandt & Danielsson has acted as legal advisor to Moberg Pharma in connection with an approximately MSEK 148 private placement of shares in Moberg Pharma and an issuance of new bonds at an amount of MSEK 215.

The proceeds from the private placement and the issuance of new bonds will be used to finance the company’s acquisition of DermoPlast®, an anesthetic spray used externally for relief of pain and itching from skin chaps and skin injuries, from Prestige Brands.

Gernandt & Danielsson has advised Moberg Pharma with a team consisting of Partner Mikael Borg, Senior Associates Adrian Della Morte Pålstam and Gabriel Zsiga, and Associates Fredrik Haräng and Katarina Odelberg.